Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan-Dec:28:10760296221084300.
doi: 10.1177/10760296221084300.

Sulodexide: A Benefit for Cardiovascular Sequelae of Long COVID Patients?

Győző Szolnoky  1 , Alejandro José González-Ochoa  2   3
Affiliations

Sulodexide: A Benefit for Cardiovascular Sequelae of Long COVID Patients?

Győző Szolnoky et al. Clin Appl Thromb Hemost. 2022 Jan-Dec.
No abstract available

Keywords: COVID-19; anticoagulants; endothelial dysfunction; sulodexide.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Magnani HN. Rationale for the role of heparin and related GAG antithrombotics in COVID-19 infection. Clin Appl Thromb Hemost. 2021;27. doi: 10.1177/1076029620977702 - DOI - PMC - PubMed
    1. Gonzalez Ochoa AJ, Raffetto J, Hernandez Ibarra AG, et al. Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial. Thromb Haemostasis. 2021;121(7):944-954. doi: 10.1055/a-1414-5216. - DOI - PubMed
    1. Townsend L, Fogarty H, Dyer A, et al. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J Thromb Haemost. 2021;19(4):1064-1070. doi: 10.1111/jth.15267. - DOI - PMC - PubMed
    1. Fogarty H, Townsend L, Morrin H, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19(10):2546-2553. doi: 10.1111/jth.15490. - DOI - PMC - PubMed
    1. Vollenberg R, Tepasse PR, Ochs K, et al. Indications of persistent glycocalyx damage in convalescent COVID-19 patients: a prospective multicenter study and hypothesis. Viruses. 2021;13(11):2324. doi: 10.3390/v13112324. - DOI - PMC - PubMed

Substances